2,317
Views
15
CrossRef citations to date
0
Altmetric
Miscellany

DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.

, , , &
Pages 696-708 | Received 08 Jun 2018, Accepted 01 Jul 2018, Published online: 19 Jan 2019

References

  • Calcagno, D. Q.; Cardoso Smith, M. A.; Burbano, R. R. Cancer Type-Specific Epigenetic Changes: Gastric Cancer Methods Mol Biol. 2015; 1238:79–101
  • Baylin, S. B. Mechanisms Underlying Epigenetically Mediated Gene Silencing in Cancer. Semin. Cancer Biol. 2002, 12(5), 331–337.
  • Jones, P. A. The DNA Methylation Paradox. Trends Genet. 1999, 15(1), 34–37.
  • Robertson, K. D.; Jones, P. A. DNA Methylation: Past, Present and Future Directions. Carcinogenesis 2000, 21(3), 461–467.
  • Bestor, T. H.; Ingram, V. M. Two DNA Methyltransferases from Murine Erythroleukemia Cells: Purification, Sequence Specificity, and Mode of Interaction with DNA. Proc. Natl. Acad. Sci. U. S. A. 1983. 80(18):5559–63
  • Okano, M.; Xie, S.; Li, E. Cloning and Characterization of a Family of Novel Mammalian DNA (Cytosine-5) Methyltransferases. Nat. Genet. 1998, 19, 219–220.
  • Xie, S.; Wang, Z.; Okano, M.; Nogami, M.; Li, Y.; He, W. W.; Okumura, K.; Li, E. Cloning, Expression and Chromosome Locations of the Human DNMT3 Gene Family. Gene 1999, 236(1), 87–95.
  • Peters, S. L.; Hlady, R. A.; Opavska, J.; Klinkebiel, D.; Pirruccello, S. J.; Talmon, G. A.; Sharp, J. G.; Wu, L.; Jaenisch, R.; Simpson, M. A.; Karpf, A. R.; Opavsky, R. Tumor Suppressor Functions of Dnmt3a and Dnmt3b in the Prevention of Malignant Mouse Lymphopoiesis. Leukemia 2014, 28, 1138–1142.
  • Peters, S. L.; Hlady, R. A.; Opavska, J.; Klinkebiel, D.; Novakova, S.; Smith, L. M.; Lewis, R. E.; Karpf, A. R.; Simpson, M. A.; Wu, L.; Opavsky, R. Essential Role for Dnmt1 in the Prevention and Maintenance of MYC-Induced T-Cell Lymphomas. Mol. Cell. Biol. 2013, 33(21), 4321–4333.
  • Zhang, W.; Xu, J. DNA Methyltransferases and Their Roles in Tumorigenesis. Biomark. Res. 2017, 5(1), 1.
  • Choi, W. J.; Chung, H.-J.; Chandra, G.; Alexander, V.; Zhao, L. X.; Lee, H. W.; Nayak, A.; Majik, M. S.; Kim, H. O.; Kim, J.-H.; Lee, Y. B.; Ahn, C. H.; Lee, S. K.; Jeong, L. S. Fluorocyclopentenyl-Cytosine with Broad Spectrum and Potent Antitumor Activity. J. Med. Chem. 2012, 55(9), 4521–4525.
  • Peters, G. J.; Smid, K.; Vecchi, L.; Kathmann, I.; Sarkisjan, D.; Honeywell, R. J.; Losekoot, N.; Ohne, O.; Orbach, A.; Blaugrund, E.; Jeong, L. S.; Lee, Y. B.; Ahn, C. H.; Kim, D. J. Metabolism, Mechanism of Action and Sensitivity Profile of Fluorocyclopentenylcytosine (RX-3117; TV-1360). Invest New Drugs 2013, 31, 1444–1457.
  • Rasco, D.; Peterson, C.; Benaim, E.; Merchan, R. RX3117, an Oral Antimetabolite Nucleoside Shows Activity in Subjects with Pancreatic Cancer. Preliminary Results of Stage 1 of the Phase 1a/2b Study. J. Clin. Oncol. 2017, 35(4_suppl), 445.
  • Honeywell, R. J.; Sarkisjan, D.; Kathmann, I.; Kristensen, M. H.; Peters, G. J. Sensitive Liquid Chromatography Mass Spectrometry (LC-MS) Assay Reveals Novel Insights on DNA Methylation and Incorporation of Gemcitabine, Its Metabolite Difluorodeoxyuridine, Deoxyuridine, and RX-3117 into DNA. Nucleosides, Nucleotides and Nucleic Acids 2016, 35(10–12).
  • Lemos, C.; Kathmann, I.; Giovannetti, E.; Belien, J. A.; Scheffer, G. L.; Calhau, C.; Jansen, G.; Peters, G. J. Cellular Folate Status Modulates the Expression of BCRP and MRP Multidrug Transporters in Cancer Cell Lines from Different Origins. Mol.Cancer Ther. 2009, 8, 3, 655–664.
  • Yang, M. Y.; Lee, Y. B.; Ahn, C. H.; Kaye, J.; Fine, T.; Kashi, R.; Ohne, O.; Smid, K.; Peters, G. J.; Kim, D. J. A Novel Cytidine Analog, RX-3117, Shows Potent Efficacy in Xenograft Models, Even in Tumors That Are Resistant to Gemcitabine. Anticancer Res. 2014, 34(12), 6951–6959.
  • Sigmond, J.; Kroep, J. R.; Loves, W.; Codacci-Pisanelli, G.; Peters, G. J. Quantitative Real Time PCR of Deoxycytidine Kinase MRNA by Light Cycler PCR in Relation to Enzyme Activity and Gemcitabine Sensitivity. Cancer Lett. 2004, 213, 173–179.
  • Kristensen, M. H.; Weidinger, M.; Bzorek, M.; Pedersen, P. L.; Mejer, J. Correlation between Thymidylate Synthase Gene Variants, RNA and Protein Levels in Primary Colorectal Adenocarcinomas. J. Int. Med. Res. 2010, 38(2), 484–497.
  • Gopalakrishnan, S.; Van Emburgh, B. O.; Shan, J.; Su, Z.; Fields, C. R.; Vieweg, J.; Hamazaki, T.; Schwartz, P. H.; Terada, N.; Robertson, K. D. A Novel DNMT3B Splice Variant Expressed in Tumor and Pluripotent Cells Modulates Genomic DNA Methylation Patterns and Displays Altered DNA Binding. Mol. Cancer Res. 2009, 7(10), 1622–1634.
  • Subramaniam, D.; Thombre, R.; Dhar, A.; Anant, S. DNA Methyltransferases: A Novel Target for Prevention and Therapy. Front. Oncol. 2014, 4:80.
  • Robertson, K. D.; Keyomarsi, K.; Gonzales, F. A.; Velicescu, M.; Jones, P. A. Differential MRNA Expression of the Human DNA Methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S Phase Transition in Normal and Tumor Cells. Nucleic Acids Res. 2000, 28(10), 2108–2113.
  • Du, Z.; Song, J.; Wang, Y.; Zhao, Y.; Guda, K.; Yang, S.; Kao, H. Y.; Xu, Y.; Willis, J.; Markowitz, S. D.; Sedwick, D.; Ewing, R. M.; Wang, Z. DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitination. Sci. Signal. 2010, 3(146), ra80.
  • Sarkisjan, D.; Steenbergen, R. D. M.; Cloos, J.; Peters, G. J. Re-Emerging Antimetabolites with Novel Mechanism of Action with Respect to Epigenetic Regulation: Basic Aspects. In Chemotherapy for Leukemia: Novel Drugs and Treatment; Chapter 18 (Ed: T. Ueda). Springer Nature, Singapore Pte Ltd, 2017; pp. 311–326
  • Farias, N.; Ho, N.; Butler, S.; Delaney, L.; Morrison, J.; Shahrzad, S.; Coomber, B. L. The Effects of Folic Acid on Global DNA Methylation and Colonosphere Formation in Colon Cancer Cell Lines. J. Nutr. Biochem. 2015, 26(8), 818–826.